EQS-NVR: Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG with the objective of Europe-wide distribution
Werte in diesem Artikel
|
EQS Total Voting Rights Announcement: Marinomed Biotech AG
/ Total Voting Rights Announcement
Werbung Werbung Marinomed Biotech AG herewith announces pursuant to Sec. 135 Para. 1 of the Stock Exchange Act, that due to the resolution on the capital increase of December 05, 2024, the total number of voting rights as at the end of December 2024 has increased to 1,778,333 voting rights, and the Company's new share capital amounts to EUR 1,778,333. The change in the total number voting rights took effect upon entry in the commercial register on December 19, 2024.
31.12.2024 CET/CEST |
| Language: | English |
| Company: | Marinomed Biotech AG |
| Hovengasse 25 | |
| 2100 Korneuburg | |
| Austria | |
| Internet: | www.marinomed.com |
| End of News | EQS News Service |
|
|
2055907 31.12.2024 CET/CEST
Ausgewählte Hebelprodukte auf Marinomed Biotech
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Marinomed Biotech
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Marinomed Biotech AG
Analysen zu Marinomed Biotech AG
Keine Analysen gefunden.